ARTA
UTHR icon

A.R.T. Advisors’s United Therapeutics UTHR Stock Holding History

A.R.T. Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,257
Closed -$343K – 102
2020
Q4 		$343K Sell
2,257
-1,100
-33% -$144K 1.59% 26
2020
Q3 		$339K Hold
3,357
– – 1.92% 11
2020
Q2 		$406K Buy
3,357
+1,100
+49% +$124K 0.61% 44
2020
Q1 		$214K Sell
2,257
-17,900
-89% -$1.7M 3.75% 13
2019
Q4 		$1.77M Buy
+20,157
New +$1.77M 0.09% 344
2018
Q3 		– Sell
-3,857
Closed -$436K – 1733
2018
Q2 		$436K Sell
3,857
-15,600
-80% -$1.71M 0.02% 973
2018
Q1 		$2.19M Buy
19,457
+4,503
+30% +$572K 0.09% 349
2017
Q4 		$2.21M Buy
+14,954
New +$1.9M 0.1% 339
2017
Q3 		– Sell
-6,354
Closed -$824K – 1686
2017
Q2 		$824K Buy
+6,354
New +$793K 0.04% 600
2017
Q1 		– Sell
-32,200
Closed -$4.62M – 1732
2016
Q4 		$4.62M Buy
32,200
+26,100
+428% +$3.33M 0.28% 70
2016
Q3 		$720K Buy
+6,100
New +$733K 0.23% 122
2016
Q2 		– Sell
-52,330
Closed -$5.83M – 1654
2016
Q1 		$5.83M Buy
52,330
+30,100
+135% +$3.81M 0.26% 71
2015
Q4 		$3.48M Sell
22,230
-73,216
-77% -$10.7M 0.17% 151
2015
Q3 		$12.5M Buy
95,446
+91,584
+2,371% +$14.7M 0.46% 25
2015
Q2 		$671K Buy
+3,862
New +$695K 0.02% 882
2014
Q3 		– Sell
-30,389
Closed -$2.69M – 1539
2014
Q2 		$2.69M Sell
30,389
-15,540
-34% -$1.49M 0.14% 201
2014
Q1 		$4.32M Sell
45,929
-10,531
-19% -$1.08M 0.23% 105
2013
Q4 		$6.38M Buy
+56,460
New +$5.09M 0.34% 46
2013
Q3 		– Sell
-85,979
Closed -$5.66M – 1512
2013
Q2 		$5.66M Buy
+85,979
New +$5.54M 0.19% 156

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

A.R.T. Advisors's UTHR Position: Q1 2021 in Review

A.R.T. Advisors sold out of United Therapeutics (UTHR) in Q1 2021, closing a stake of 2,257 shares — an estimated $343K sold.

A.R.T. Advisors first reported a position in UTHR in Q2 2013 and held it in 19 quarters. The position peaked at $12.5M in Q3 2015. 391 funds tracked by Wall St. Rank hold UTHR as of Q1 2021.

  • A.R.T. Advisors reported no remaining United Therapeutics position as of Q1 2021 after selling out during the quarter.
  • A.R.T. Advisors sold 2,257 United Therapeutics shares in Q1 2021, an estimated $343K.
  • A.R.T. Advisors first reported a position in United Therapeutics in Q2 2013 and held it in 19 quarters.
  • A.R.T. Advisors's United Therapeutics position peaked at $12.5M in Q3 2015.
  • 391 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2021.

Based on A.R.T. Advisors's 13F filing for Q1 2021, filed 17 May 2021.